{
    "id": "0700",
    "question": "A 76-year-old woman visits a physician for a general medical examination. She is asymptomatic. Six months prior, she had a cerebral stroke with left hemiparesis, from which she has almost completely recovered with physiotherapy. She has a history of hypertension and atrial fibrillation (AF). She has no significant ischemic, valvular, or structural heart disease. She takes metoprolol, amlodipine, warfarin, and atorvastatin. Blood pressure is 125/70 mm Hg, pulse is 75/min with an irregular rhythm. Respirations are 13/min. She has a minor limp and weakness in her left arm and leg. Heart exam shows no abnormalities other than irregular beats. To assess adherence and therapeutic efficacy in this patient, which of the following studies should be ordered?",
    "options": {
        "A": "Echocardiogram",
        "B": "International normalized ratio",
        "C": "Partial thromboplastin time",
        "D": "Serum drug levels"
    },
    "answer": "B",
    "predict": "To assess adherence and therapeutic efficacy in this patient, let's break down the key points: 1. **Patient's History**: The patient had a cerebral stroke with left hemiparesis six months ago, which she has almost completely recovered from. She has a history of hypertension and atrial fibrillation (AF), and is taking warfarin for AF. 2. **Current Medications**: - Metoprolol (a beta-blocker for hypertension and heart failure) - Amlodipine (a calcium channel blocker for hypertension) - Warfarin (an anticoagulant for atrial fibrillation) - Atorvastatin (a statin for cholesterol management) 3. **Clinical Findings**: - Blood pressure is within normal limits. - Pulse is 75/min with an irregular rhythm, consistent with atrial fibrillation. - The patient has a minor limp and weakness in her left arm and leg, which could be related to her previous stroke. Given these points, the primary concern is the patient's atrial fibrillation (AF) and the potential risk of thromboembolic events. To assess adherence and therapeutic efficacy of warfarin, we need to monitor the International Normalized Ratio (INR), as it reflects the patient's anticoagulation status. **Step-by-Step Thinking:** - **Option A (Echocardiogram)**: While useful for evaluating heart structure and function, it is not directly relevant to assessing warfarin efficacy or adherence. - **Option B (International Normalized Ratio)**: This is the correct choice because it measures the blood's clotting ability, which is directly related to warfarin's anticoagulant effect. It is a standard method to monitor warfarin therapy. - **Option C (Partial thromboplastin time)**: This test is used to evaluate the intrinsic and common coagulation pathways, but it is not as specific for warfarin therapy as INR. - **Option D (Serum drug levels)**: While monitoring drug levels can be useful, it is not typically used for warfarin as INR is a more direct measure of anticoagulation status. **Output:** ```json { \"step_by_step_thinking\": \"To assess adherence and therapeutic efficacy of warfarin in a patient with atrial fibrillation, we need to monitor the International Normalized Ratio (INR), as it directly reflects the patient's anticoagulation status.\", \"answer_choice\": \"B\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 14.639697074890137
}